Oncology
Cancer metastasis in xenograft models is altered by interleukin-1 blockade
Published in Cancer Weekly, April 17th, 2006
"Interleukin 1 (IL-1) is a pluripotent cytokine that promotes angiogenesis, tumor growth, and metastasis in experimental models; its presence in some human cancers is associated with aggressive tumor biology. The purpose of these studies was to characterize the role of IL-1 in human cancers and determine if inhibition of IL-1 via its receptor antagonist, IL-1Ra, alters tumor growth and metastatic potential," researchers in the United States report.
"IL-1 mRNA or protein levels were determined in clinical tumor samples, cancer cell lines, and xenografts using...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-04-17)
More Articles from Cancer Weekly
- Acute Myeloid Leukemia
Poor prognosis in pediatric acute myeloid leukemia linked to KIT mutations - Breast Cancer
Mammographically occult invasive breast cancer detection by MRI evaluated - Colon Cancer
Colon cancer development inhibited by aspirin and NSAIDs - Drug Development
Alcyopterosin A and illudalane derivatives evaluated as anticancer agents - Natural Products
Cashew waste products and cashew nut shell liquid used as cancer chemopreventive agents - Acute Myeloid Leukemia
Acute myeloid leukemia patients with KIT-D816 mutations linked to poor prognosis - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
